Skip to main content
Clinical Trials/CTRI/2021/08/035334
CTRI/2021/08/035334
Not yet recruiting
Phase 3

A prospective community based study for the evaluation of Rajapravartani Vati in the Management of Primary Dysmenorrhoea

Central Council for Research in Ayurvedic Sciences CCRAS0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: N944- Primary dysmenorrhea
Sponsor
Central Council for Research in Ayurvedic Sciences CCRAS
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Central Council for Research in Ayurvedic Sciences CCRAS

Eligibility Criteria

Inclusion Criteria

  • i.Young women of age 18 \-25 years of scheduled Caste community
  • ii.Self\-reported history consistent with primary dysmenorrheal of moderate to severe nature (Mild: doesnâ??t interfere in normal activities, Moderate: slightly interferes in daily routines but can be managed by painkillers, Severe: markedly prevents daily life activities) with a self\-reported menstrual cycle of averaging 21\-35 days.
  • iii.Willing and able to participate in the study (Written informed consent or assent).

Exclusion Criteria

  • i.Irregular Cycles.
  • ii.Cases of secondary Dysmenorrhea
  • iii.Pain abdomen associated with excessive bleeding per vagina.
  • iv.Presence of persistent pelvic pain throughout the menstrual cycle.
  • v.Known case / diagnosis /h/o of leiomyoma of uterus, ovarian cyst, endometriosis.
  • vi.Associated with clinically diagnosed pelvic inflammatory disease (PID),
  • vii.Associated with any pre\-diagnosed or clinically diagnosed systemic disorders likely to influence menstrual cycle.
  • viii.Patients with Hb \<\= 7 gm %
  • ix.History of malignancy of pelvic organs.
  • x.Diagnosed cases Hypo/hyperthyroidism.

Outcomes

Primary Outcomes

Not specified

Similar Trials